Researchers conducted a target trial emulation to compare the effects of SGLT-2 inhibitor and DPP-4 inhibitor use on epilepsy among patients with type 2 diabetes.

There is a difference between the terms "tardive dyskinesia" and "tardive syndrome" that clinicians should be aware of when providing care.

Researchers conducted a retrospective and prospective observational study to assess the effect of denosumab plus romosozumab on severe postmenopausal osteoporosis.